{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for glutathione root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
INN:remternetug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03797391: Phase 1/Phase 2 Interventional Recruiting Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03611569: Phase 1 Interventional Completed Healthy
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mibavademab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03838731: Phase 2 Interventional Completed Cat Allergy
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:domvanalimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04348136: Phase 2/Phase 3 Interventional Active, not recruiting Mucopolysaccharidosis II
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:eltivutabart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03500380: Phase 2/Phase 3 Interventional Active, not recruiting Breast Neoplasms
(2018)
Source URL:
Class:
PROTEIN